Sharon M. Bartosh

Sharon M. Bartosh

Auto-generated profile, based on publicly available information

Sharon M. Bartosh

Division of Pediatric Nephrology, Department of Pediatrics University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2025 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
DGDorey A. Glenn
Dorey A. Glenn
ACAshley W. Carver
Ashley W. Carver
MHMargaret E. Helmuth
Margaret E. Helmuth
ASAbigail R. Smith
Abigail R. Smith
RLRichard A. Lafayette
Richard A. Lafayette
OGon behalf of the CureGN IgA Working Group
on behalf of the CureGN IgA Working Group
Key Points: Defining risk of kidney function loss in IgA nephropathy and IgA vasculitis with nephritis is important for patient counseling and risk-based enrollment of clinical trials. Proteinuria trajectory over 2 years can uniquely identify patients at risk of loss of kidney function or kidney failure. Children and adults with the highest levels of proteinuria had a higher risk of progressive kidney disease compared with those with intermediate levels. Background: Identifying patients with IgA nephropathy at risk of disease progression is critical for clinical decision making, risk-based patient counseling, and optimal enrollment of clinical trials. Methods: Patients with IgA nephropathy and IgA vasculitis with nephritis were enrolled in the Cure Glomerulonephropathy Network, a multicenter observational cohort study. Children and adults were analyzed separately in four cohorts: (1) full, (2) incident, (3) prevalent, and (4) histology. Groups were defined using latent class trajectory modeling using proteinuria measurements over 2 years. Linear mixed models were used to calculate predicted eGFR slope. In adults, Cox proportional hazard models were used to model time to kidney failure or 40% eGFR decline as a function of the proteinuria trajectory group. Results: Of 919 patients with IgA nephropathy/IgA vasculitis with nephritis enrolled into the Cure Glomerulonephropathy Network, 368 adults and 234 children were included in the analysis. In the full adult cohort, group 1 had the lowest levels of proteinuria (interquartile range [IQR], 0.1–0.4 g/g), while groups 2 and 3 had intermediate and higher levels of proteinuria (IQR, 0.5–1.5 and IQR, 1.8–4.1 g/g), respectively. The average predicted time to eGFR 90, 16, and 8 years and >90, 67, and 11 years for proteinuria trajectory groups 1, 2, and 3 in the full adult and pediatric cohorts, respectively. In adults, adjusting for age, eGFR at enrollment, immunosuppression exposure, and hypertension, group 3 membership was associated with 3.13 (95% confidence interval [CI], 1.84 to 5.33), 1.98 (95% CI, 0.97 to 4.06), and 3.36 (95% CI, 1.59 to 7.13) times higher hazard of progressing to a composite outcome compared with group 2 membership in the full, prevalent, and histology cohorts, respectively, but not associated with progression in the incident cohort. Conclusions: Proteinuria trajectory is a major predictor of disease progression in patients with IgA nephropathy.

2 August 2022 in Pediatric Transplantation
Verified
Journal Article
Open access
RERachel M. Engen
Rachel M. Engen
JSJodi M. Smith
Jodi M. Smith
SBSharon M. Bartosh
Sharon M. Bartosh
Background: A new Kidney Allocation System (KAS) was implemented in the United States in 2014 with the goal of improving equity and utility.Methods: In this study, we compare outcomes for kidney‐alone candidates less than 18 years of age, at the time of listing, in the 5 years prior to and following policy implementation using Organ Procurement and Transplantation Network data.Results: While the pediatric deceased donor transplant rate increased under KAS, this increase was due solely to improved access for children aged 11–17 years; there was an 18.9% decrease in the deceased donor transplant rate among children 0–5 years old, from 117.94 to 95.8 transplants per 100 person‐years (p = .001). The cumulative incidence of deceased donor transplantation by 1 year after listing decreased from 39.3% in the pre‐KAS era to 35.5% in the post‐KAS era (p = .004), a decline that was driven entirely by longer wait times for children 0–5 years old (p = .017). Candidates with a calculated panel reactive antibody of 98%–100% experienced a significant increase in transplant rate, but there was no change in transplant rate for Black or Hispanic candidates.Conclusion: Overall, KAS increased transplantation access for teenaged and highly sensitized candidates but resulted in decreased access for the youngest children with no improvement in racial/ethnic equality.

22 September 2022 in Pediatric Transplantation
Verified
Journal Article
Open access
RERachel Engen
Rachel Engen
DSDanielle Shepherd
Danielle Shepherd
MBMiranda C. Bradford
Miranda C. Bradford
JFJulia Foutz
Julia Foutz
SBSharon M. Bartosh
Sharon M. Bartosh
JSJodi M. Smith
Jodi M. Smith
Background: The United States organ allocation policies prioritize kidney–pancreas and other multiorgan candidates above pediatric kidney‐alone candidates, but the effects of these policies are unclear.Methods: We used OPTN data to describe trends in multiorgan and kidney–pancreas transplantation and identify 377 next‐sequential pediatric kidney‐alone candidates between 4/1/2015 and 10/31/2019 for individual‐level analysis.Results: Eleven percent of all kidneys were allocated as part of a multiorgan or kidney–pancreas transplant and 6% of pediatric kidney candidates were impacted. Pediatric next‐sequential candidates accrued a median of 118 days (IQR 97–135 days) of additional wait time, and this was significantly longer for children who were Hispanic (p = .02), blood type B or O (p = .01), or had a cPRA ≥20% (p < .01). Eight pediatric next‐sequential candidates (2%) were removed from the waitlist due to death or “too sick to transplant.” 63% were transplanted with a kidney with a higher KDPI than the original multiorgan match (p < .01). Donor service areas with higher volumes of kidney–pancreas transplants had significantly longer additional wait times for pediatric next‐sequential candidates (p = .01).Conclusions: Current allocation policy results in longer waiting times and higher KDPI kidneys for pediatric kidney candidates. As multiorgan transplant volume is increasing, further consideration of allocation policy is necessary to maximize equality and utility.

31 October 2024 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
CDChloe E. Douglas
Chloe E. Douglas
MBMiranda C. Bradford
Miranda C. Bradford
RERachel M. Engen
Rachel M. Engen
YNYue-Harn Ng
Yue-Harn Ng
AWAaron Wightman
Aaron Wightman
JSJodi M. Smith
Jodi M. Smith
Key Points: This is the largest US cohort study investigating neighborhood socioeconomic deprivation and outcomes among pediatric kidney transplant recipients. High neighborhood deprivation was associated with worse graft survival and lower access to preemptive and living donor transplantation. Findings demonstrate inequities in pediatric kidney transplantation associated with neighborhood-level factors that warrant intervention. Background: Social determinants of health shape a child's transplant course. We describe the association between neighborhood socioeconomic deprivation, transplant characteristics, and graft survival in US pediatric kidney transplant recipients. Methods: US recipients younger than 18 years at the time of listing transplanted between January 1, 2010, and May 31, 2022 ( N =9178) were included from the Scientific Registry of Transplant Recipients. Recipients were stratified into three groups according to Material Community Deprivation Index score, with greater score representing higher neighborhood socioeconomic deprivation. Outcomes were modeled using multivariable logistic regression and Cox proportional hazards models. Results: Twenty-four percent ( n =110) of recipients from neighborhoods of high socioeconomic deprivation identified as being of Black race, versus 12% ( n =383) of recipients from neighborhoods of low socioeconomic deprivation. Neighborhoods of high socioeconomic deprivation had a much greater proportion of recipients identifying as being of Hispanic ethnicity (67%, n =311), versus neighborhoods of low socioeconomic deprivation (17%, n =562). The hazard of graft loss was 55% higher (adjusted hazards ratio [aHR], 1.55; 95% confidence interval [CI], 1.24 to 1.94) for recipients from neighborhoods of high versus low socioeconomic deprivation when adjusted for base covariates, race and ethnicity, and insurance status, with 59% lower odds (adjusted odds ratio [aOR], 0.41; 95% CI, 0.30 to 0.56) of living donor transplantation and, although not statistically significant, 8% lower odds (aOR, 0.92; 95% CI, 0.72 to 1.19) of preemptive transplantation. The hazard of graft loss was 41% higher (aHR, 1.41; 95% CI, 1.25 to 1.60) for recipients from neighborhoods of intermediate versus low socioeconomic deprivation when adjusted for base covariates, race and ethnicity, and insurance status, with 27% lower odds (aOR, 0.73; 95% CI, 0.66 to 0.81) of living donor transplantation and 11% lower odds (aOR, 0.89; 95% CI, 0.80 to 0.99) of preemptive transplantation. Conclusions: Children from neighborhoods of high socioeconomic deprivation have worse graft survival and lower utilization of preemptive and living donor transplantation. These findings demonstrate inequities in pediatric kidney transplantation that warrant further intervention.

16 August 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
RERachel M. Engen
Rachel M. Engen
SBSharon M. Bartosh
Sharon M. Bartosh
JSJodi M. Smith
Jodi M. Smith
JPJames D. Perkins
James D. Perkins
LHLyndsay A. Harshman
Lyndsay A. Harshman
IgA nephropathy (IgAN) is associated with a risk for post-transplant recurrence. Data are limited regarding graft loss attributable to recurrence of IgAN among pediatric and young adult kidney transplant (KT) recipients. This was a retrospective cohort study of patients aged 0 to 25 years from the Scientific Registry of Transplant Recipients who received a primary KT for IgAN. Patients with history of KT attributable to renal dysplasia were comparators. Outcomes included the incidence of graft loss attributable to IgAN recurrence, association with donor type, and post-transplant corticosteroid use. 5475 transplant recipients were included, with 1915 patients with IgAN and 3560 with renal dysplasia. In a multivariable Cox proportional hazards model, IgAN was associated with higher risk of graft loss (aHR 1.35, 95%CI 1.21-1.50, p<0.001) compared to dysplasia. Graft loss was attributed to recurrent disease in 5.4% of patients with IgAN. In a multivariable competing risks analysis, IgAN patients receiving a parental living donor kidney were more likely to report graft loss from recurrent disease compared to persons with a nonparental living donor (aHR 0.52 (95%CI 0.31-0.91) p=0.02). Post-transplant prednisone use was not associated with improved graft survival (p=0.2). This data challenges existing paradigms in post-transplant management of patients with IgAN.

15 July 2024 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
RERachel M. Engen
Rachel M. Engen
KSKristen Sgambat
Kristen Sgambat
PVPriya S. Verghese
Priya S. Verghese
AJAmrish Jain
Amrish Jain
JSJodi Smith
Jodi Smith
SBSharon Bartosh
Sharon Bartosh